Pivotal Phase III Trial of Two Dose Levels of Denileukin Diftitox for the Treatment of Cutaneous T-Cell LymphomaElise A. Olsen, Jean Nichols, Eric C. Vonderheid et al.|Journal of Clinical Oncology|2001Cited by 610